Dashboard
Manage Tickers

ALVOAlvotech

Nasdaq alvotech.com


$ 13.54 $ -0.19 (-1.38 %)    

Thursday, 23-May-2024 15:07:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -8.61 (-1.87 %)
DIA $ 398.57 $ -6.59 (-1.66 %)
SPY $ 530.36 $ -8.03 (-1.51 %)
TLT $ 91.26 $ -0.61 (-0.67 %)
GLD $ 225.37 $ -3.15 (-1.44 %)
$ 14
$ 13.73
$ 13.39 x 100
$ 0.00 x 0
$ 13.25 - $ 13.73
$ 6.70 - $ 18.00
405,308
na
3.74B
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alvotech-now-sees-fy24-revenue-of-400m-500m-est-318575m
Alvotech Now Sees FY24 Revenue Of $400M-$5...
05/21/2024 21:33:10

Alvotech tightened guidance for EBIDTA to $100 - $150 million for the full year.

alvotech-q1-2024-sales-36894m-miss-45000m-estimate
Alvotech Q1 2024 Sales $36.894M Miss $45.0...
05/21/2024 21:22:29

alvotech-q1-2024-gaap-eps-089-up-from-124-yoy
Alvotech Q1 2024 GAAP EPS $(0.89) Up From ...
05/21/2024 21:20:08

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.89) per share. This is a 28.23 percent increase over losses of $(1.24) ...

stocks-hold-steady-on-mixed-fed-remarks-first-solar-rallies-bitcoin-falls-below-70000-whats-driving-markets-tuesday
Stocks Hold Steady On Mixed Fed Remarks, F...
05/21/2024 16:42:40

It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.

Core News & Articles
Alvotech And Dr. Reddy's Enter Collaborato...
05/21/2024 12:05:27

Core News & Articles
Reported Earlier, Teva And Alvotech Announ...
05/21/2024 06:57:27

alvotech-announced-positive-topline-results-from-a-confirmatory-clinical-study-for-avt05-alvotechs-proposed-biosimilar-to-simponi-and-simponi-aria-golimumab
Alvotech Announced Positive Topline Result...
04/24/2024 08:02:35

fifth-third-bancorp-reports-upbeat-earnings-joins-metropolitan-bank-holding-paramount-global-and-other-big-stocks-moving-higher-on-friday
Fifth Third Bancorp Reports Upbeat Earning...
04/19/2024 14:40:21

Core News & Articles
Alvotech Inks Long-Term Agreement With A S...
04/19/2024 10:11:54

"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing...

Core News & Articles
Alvotech, Teva Announce US FDA Approval Of...
04/16/2024 21:33:05

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of SELARSDI ...

alvotech-receives-fda-approval-for-selarsdi-for-moderate-to-severe-plaque-psoriasis
Alvotech Receives FDA Approval For Selarsd...
04/16/2024 19:46:42

Alvotech receives FDA approval for Selarsdi for moderate to severe plaque psoriasisAdult patients with:moderate to severe plaqu...

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday
Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

alvotech-announces-increased-the-companys-share-capital-by-an-amount-of-130k-by-issuing-13m-ordinary-shares
Alvotech Announces Increased The Company's...
03/22/2024 20:24:51

Alvotech (NASDAQ:ALVO) (the "Company"), a global biotech company specializing in the development and manufacture of bio...

barclays-maintains-overweight-on-alvotech-raises-price-target-to-20
Barclays Maintains Overweight on Alvotech,...
03/22/2024 10:42:15

Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and raises the price target from $17 to $20.

alvotech-fy-2023-gaap-eps-243-misses-107-estimate-sales-93400m-miss-112470m-estimate
Alvotech FY 2023 GAAP EPS $(2.43) Misses $...
03/20/2024 20:18:38

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(1.07) by...

earnings-scheduled-for-march-20-2024
Earnings Scheduled For March 20, 2024
03/20/2024 09:32:15

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per s...

alvotechs-earnings-a-preview
Alvotech's Earnings: A Preview
03/19/2024 14:01:07

why-is-generic-drugs-player-teva-pharma-stock-trading-higher-today
Why Is Generic Drugs Player Teva Pharma St...
02/26/2024 13:48:24

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.

Core News & Articles
Late Friday, Alvotech And Teva Pharmaceuti...
02/26/2024 12:22:42

alvotech-has-accepted-an-offer-from-investors-for-the-sale-of-1013m-shares-for-approximately-166m-at-1641share-or-isk-2250share-the-transaction-will-be-made-on-the-nasdaq-iceland-exchange
Alvotech Has Accepted An Offer From Invest...
02/26/2024 09:31:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION